Medical Testing

Analysisi of Geographic Accessibility of COVID-19 Test to Treat Sites by Race, Ethnicity, Age, and Rurality

Wed, 2022-11-09 19:34 — mike kraft

Geographic Accessibility of COVID-19 Test to Treat Sites This cross-sectional study explores geographic disparities in antiviral access by quantifying the accessibility of COVID-19 Test to Treat sites for subpopulations by race, ethnicity, age, and rurality. JAMANetworkOpen

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Latest COVID-19 Variants Can Evade Vaccine Protection, According to New Data

Wed, 2022-11-09 10:10 — mike kraft

Time Magazine

The Latest COVID-19 Variants Can Evade Vaccine Protection, According to New Data

New lab data suggest that vaccines and prior infections may not offer enough protection against several new COVID-19 variants cropping up in the U.S. and around the world.

Dr. David Ho, director of Columbia University’s Aaron Diamond AIDS Research Center, and his team reported the results from a set of studies published in the journal Nature. They showed how well some of the latest variants—BQ.1, BQ.1.1, XBB, and XBB.1, which were all derived from Omicron—are evading both vaccine-derived and infection-derived immunity.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Latest COVID-19 Variants Can Evade Vaccine Protection, According to New Data
Log in or register to post comments

UK approves Pfizer-BioNTech's COVID booster targeting Omicron BA.4/5

Wed, 2022-11-09 09:57 — mike kraft

UK approves Pfizer-BioNTech's COVID booster targeting Omicron BA.4/5 Britain's health regulator on Wednesday approved the country's first two-pronged COVID-19 booster targeting the Omicron BA.4 and BA.5 sub-variants and the original coronavirus strain. Pushkala Aripaka Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about UK approves Pfizer-BioNTech's COVID booster targeting Omicron BA.4/5
Log in or register to post comments

Opinion: OPINION After COVID and monkeypox, it's time to rethink how U.S. responds to infectious diseases

Tue, 2022-11-08 10:41 — mike kraft

After COVID and monkeypox, it's time to rethink how U.S. responds to infectious diseases The COVID-19, monkeypox, and now Ebola responses have illustrated the urgent need to re-imagine the nation’s laboratory system. Scott J. Becker USA TODAY

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Novavax says Omicron shot shows strong immune response as second booster

Tue, 2022-11-08 08:56 — mike kraft

Novavax says Omicron shot shows strong immune response as second booster Vaccine maker Novavax Inc said on Tuesday its COVID-19 shot retooled against the Omicron BA.1 variant showed a strong immune response as the fourth dose and met the main goal of strain change in a late-stage study. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Novavax says Omicron shot shows strong immune response as second booster
Log in or register to post comments

Trying to understand long covid, scientists made mini brains and infected them with coronavirus.

Mon, 2022-11-07 18:35 — mike kraft

Scientists made mini brains and infected them with coronavirus.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Trying to understand long covid, scientists made mini brains and infected them with coronavirus.
Log in or register to post comments

Paxlovid reduces risk of long Covid -USG study

Mon, 2022-11-07 10:23 — mike kraft

Paxlovid reduces risk of long Covid, Veterans Affairs study finds | CNN Paxlovid, the antiviral pill that reduces the risk of hospitalization and death from Covid-19, also reduces the risk of long Covid, according to a new study by researchers at the US Department of Veterans Affairs. Jamie Gumbrecht CNN

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Paxlovid reduces risk of long Covid -USG study
Log in or register to post comments

COVID Superspreader Events Still Exist But Probably Underreported

Mon, 2022-11-07 09:56 — mike kraft

COVID Superspreader Events Still Exist. Here's What They Look Like Now. Just because we don't hear about clusters of infections like we did in 2020 and 2021 doesn't mean they don't happen. YahooNews

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about COVID Superspreader Events Still Exist But Probably Underreported
Log in or register to post comments

Lessns learned" Two early US programs successfully traced COVID case contacts

Fri, 2022-11-04 18:03 — mike kraft

Two early US programs successfully traced COVID case contacts One report details a massive NYC effort to probe 941,035 COVID-19 cases and follow up with their contacts. CIDRAP

A pair of new studies describe how two US jurisdictions quickly mobilized teams of contact tracers to identify and isolate people exposed to SARS-CoV-2, with a massive New York City effort finding 1.4 contacts per case and a college student-led Central Pennsylvania initiative that may have led to fewer symptomatic household infections.

Country / Region Tags:

General Topic Tags: